BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND MEN1, ENSG00000133895, 4221
146 results:

  • 1. Multiregion WES of metastatic pancreatic neuroendocrine tumors revealed heterogeneity in genomic alterations, immune microenvironment and evolutionary patterns.
    Jiang Y; Dong YH; Zhao SW; Liu DY; Zhang JY; Xu XY; Chen H; Chen H; Jin JB
    Cell Commun Signal; 2024 Mar; 22(1):164. PubMed ID: 38448900
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Neuroendocrine tumors in a patient with multiple endocrine neoplasia type 1 syndrome: A case report and review of the literature.
    Deng J; Liao X; Cao H
    Medicine (Baltimore); 2023 Jul; 102(29):e34350. PubMed ID: 37478229
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Traits of Patients With Pituitary Tumors in Multiple Endocrine Neoplasia Type 1 and Comparing Different Mutation Status.
    Lin KY; Kuo YT; Cheng MF; Chen PL; Wang HP; Cheng TY; Chang CH; Kao HF; Yang SH; Li HY; Lin CH; Chou YT; Chung AK; Wu WC; Lu JY; Wang CY; Hsih WH; Wen CY; Yang WS; Shih SR
    J Clin Endocrinol Metab; 2023 Nov; 108(12):e1532-e1541. PubMed ID: 37390813
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Tuberous sclerosis complex mutations in patients with pancreatic neuroendocrine tumors. Observations on phenotypic and treatment-related associations.
    Navale P; Chatterjee D; Itani M; Trikalinos NA
    Virchows Arch; 2023 Aug; 483(2):167-175. PubMed ID: 37354253
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Insulinoma in childhood: a retrospective review of 22 patients from one referral centre.
    Melikyan M; Gubaeva D; Shadrina A; Bolmasova A; Kareva M; Tiulpakov A; Efremenkov A; Sokolov Y; Brusgaard K; Christesen HT; Andersen K; Stepanov A; Averyanova J; Makarov S; Gurevich L
    Front Endocrinol (Lausanne); 2023; 14():1127173. PubMed ID: 37152923
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Menin-MLL1 Interaction Small Molecule Inhibitors: A Potential Therapeutic Strategy for Leukemia and cancers.
    Shi Q; Xu M; Kang Z; Zhang M; Luo Y
    Molecules; 2023 Mar; 28(7):. PubMed ID: 37049787
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Case report: Metastatic pancreatic neuroendocrine tumour associated with portal vein thrombosis; successful management with subsequent pregnancies.
    Sira L; Zsíros N; Bidiga L; Barna S; Kanyári Z; Nagy EB; Guillaume N; Wild D; Rázsó K; Andó S; Balogh I; Nagy EV; Balogh Z
    Front Endocrinol (Lausanne); 2023; 14():1095815. PubMed ID: 36923225
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Hypersensitivity Reactions to Transarterial Chemoembolization with Cisplatin and Ethiodized Oil: A Retrospective Cohort Study.
    Kwok TW; Wong SM; Yu CH; Young WM
    J Vasc Interv Radiol; 2023 May; 34(5):799-806.e2. PubMed ID: 36584810
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Adult Pancreatoblastoma: Report of 3 new Cases With Genetic Diversity and Autopsy Findings.
    Machado I; López-Guerrero JA; Fernandez A; López R; García Casado Z; Ferrandez A; Llombart-Bosch A; Charville GW
    Int J Surg Pathol; 2023 Aug; 31(5):896-906. PubMed ID: 36573045
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Pitfalls in the Diagnosis of Primary Hyperparathyroidism in a Sudanese Adolescent Boy; a case disguised as rickets.
    Gafar SM; Fadlalbari GF; Abdalla AT; Mohammed SAR; Alrasheed MK; Taha IA; Abdullah MA
    BMC Endocr Disord; 2022 Dec; 22(1):322. PubMed ID: 36529731
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Sporadic and men1-related gastrinoma and Zollinger-Ellison syndrome: differences in clinical characteristics and survival outcomes.
    Massironi S; Rossi RE; Laffusa A; Eller-Vainicher C; Cavalcoli F; Zilli A; Ciafardini C; Sciola V; Invernizzi P; Peracchi M
    J Endocrinol Invest; 2023 May; 46(5):957-965. PubMed ID: 36436191
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Long-Term Outcomes for Patients with Multiple Endocrine Neoplasia Type 1 and Duodenopancreatic Neuroendocrine Neoplasms.
    Liu JB; Cai J; Dhir M; Paniccia A; Zureikat AH; Ramonell KM; McCoy KL; Carty SE; Yip L
    Ann Surg Oncol; 2022 Nov; 29(12):7808-7817. PubMed ID: 35963905
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Life expectancy and likelihood of surgery in multiple endocrine neoplasia type 1: AFCE and GTE cohort study.
    Gaujoux S; Martin GL; Mirallié E; Regenet N; Le Bras M; Pattou F; Carnaille B; Cardot-Bauters C; Groussin L; Faron M; Chanson P; Najah H; Tabarin A; Sauvanet A; Ruszniewski P; Lifante JC; Walter T; Carrère N; Caron P; Deguelte S; Delemer B; Binquet C; Jannot AS; Goudet P
    Br J Surg; 2022 Aug; 109(9):872-879. PubMed ID: 35833229
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. High-grade transformation of pancreatic neuroendocrine tumor associated with TP53 mutations: A diagnostic pitfall mimicking neuroendocrine carcinoma.
    Tanaka M; Shinozaki-Ushiku A; Kunita A; Yasunaga Y; Akamatsu N; Hasegawa K; Ushiku T
    Pathol Int; 2022 Aug; 72(8):411-418. PubMed ID: 35698921
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Molecular deciphering of primary liver neuroendocrine neoplasms confirms their distinct existence with foregut-like profile.
    de Mestier L; Nicolle R; Poté N; Rebours V; Cauchy F; Hentic O; Maire F; Ronot M; Lebtahi R; Sauvanet A; Paradis V; Ruszniewski P; Couvelard A; Cros J
    J Pathol; 2022 Sep; 258(1):58-68. PubMed ID: 35681273
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Treatment Response and Clinical Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors to Lutetium-177-DOTATATE.
    Raj N; Coffman K; Le T; Do RKG; Rafailov J; Choi Y; Chou JF; Capanu M; Dunphy M; Fox JJ; Grewal RK; Reddy RP; Riedl C; Schoder H; Bodei L; Reidy-Lagunes D
    Neuroendocrinology; 2022; 112(12):1177-1186. PubMed ID: 35609558
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Association of Pathogenic Variants in Hereditary cancer Genes With Multiple Diseases.
    Zeng C; Bastarache LA; Tao R; Venner E; Hebbring S; Andujar JD; Bland ST; Crosslin DR; Pratap S; Cooley A; Pacheco JA; Christensen KD; Perez E; Zawatsky CLB; Witkowski L; Zouk H; Weng C; Leppig KA; Sleiman PMA; Hakonarson H; Williams MS; Luo Y; Jarvik GP; Green RC; Chung WK; Gharavi AG; Lennon NJ; Rehm HL; Gibbs RA; Peterson JF; Roden DM; Wiesner GL; Denny JC
    JAMA Oncol; 2022 Jun; 8(6):835-844. PubMed ID: 35446370
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Gastric neuroendocrine neoplasms: a primer for radiologists.
    Roseland ME; Francis IR; Shampain KL; Stein EB; Wasnik AP; Millet JD
    Abdom Radiol (NY); 2022 Dec; 47(12):3993-4004. PubMed ID: 35411433
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
    Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
    Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. 68Ga-DOTANOC PET/CT in Multiple Endocrine Neoplasia 1 With Associated Adrenocortical Carcinoma.
    Basheer S; Ratheesan R; Sarma M; Palaniswamy SS; Mathews A
    Clin Nucl Med; 2022 May; 47(5):e389-e392. PubMed ID: 35195585
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.